Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-109581	Apoptosis	 76	0.313544076643383	1	13	63	558	3273	1.17040741082127
R-HSA-109606	Intrinsic Pathway for Apoptosis	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	 30	0.137241871318607	1	7	23	564	3313	1.59655575014594
R-HSA-109704	PI3K Cascade	 18	0.263250502546824	1	4	14	567	3322	1.52052928585328
R-HSA-110056	MAPK3 (ERK1) activation	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-110312	Translesion synthesis by REV1	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-110320	Translesion Synthesis by POLH	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-111447	Activation of BAD and translocation to mitochondria 	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-111465	Apoptotic cleavage of cellular proteins	 20	0.813066065533173	1	2	18	569	3318	0.684238178633976
R-HSA-111885	Opioid Signalling	 51	0.776613212183442	1	6	45	565	3291	0.804986092510559
R-HSA-111931	PKA-mediated phosphorylation of CREB	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-111933	Calmodulin induced events	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-111996	Ca-dependent events	 20	0.813066065533173	1	2	18	569	3318	0.684238178633976
R-HSA-111997	CaM pathway	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-112040	G-protein mediated events	 31	0.684070322305086	1	4	27	567	3309	0.882887972430936
R-HSA-112043	PLC beta mediated events	 30	0.657981025406859	1	4	26	567	3310	0.912317571511967
R-HSA-112308	Presynaptic depolarization and calcium channel opening	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-112310	Neurotransmitter release cycle	 37	0.460834138090378	1	6	31	565	3305	1.10957542481185
R-HSA-112311	Neurotransmitter clearance	  5	1	1	0	5	571	3331	0
R-HSA-112314	Neurotransmitter receptors and postsynaptic signal transmission	 79	0.993604523820404	1	5	74	566	3262	0.433062138375934
R-HSA-112382	Formation of RNA Pol II elongation complex 	 23	0.107352953032041	1	6	17	565	3319	1.78496916165385
R-HSA-112399	IRS-mediated signalling	 21	0.369012814190748	1	4	17	567	3319	1.30331081644567
R-HSA-112409	RAF-independent MAPK1/3 activation	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-112411	MAPK1 (ERK2) activation	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-112412	SOS-mediated signalling	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-113418	Formation of the Early Elongation Complex	 14	0.0420618470870275	1	5	9	566	3327	2.44370778083563
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	  5	1	1	0	5	571	3331	0
R-HSA-113510	E2F mediated regulation of DNA replication	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-114452	Activation of BH3-only proteins	 17	0.0898839523961524	1	5	12	566	3324	2.0124652312764
R-HSA-114508	Effects of PIP2 hydrolysis	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-114604	GPVI-mediated activation cascade	 21	0.834308558457058	1	2	19	569	3317	0.651655408222834
R-HSA-114608	Platelet degranulation 	 60	0.890663457496696	1	6	54	565	3282	0.684238178633976
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	 35	0.774190467852666	1	4	31	567	3305	0.781986489867401
R-HSA-1169091	Activation of NF-kappaB in B cells	 25	0.729986805349405	1	3	22	568	3314	0.821085814360771
R-HSA-1169408	ISG15 antiviral mechanism	 38	0.488033481110995	1	6	32	565	3304	1.08037607152733
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	 38	0.488033481110995	1	6	32	565	3304	1.08037607152733
R-HSA-1170546	Prolactin receptor signaling	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-1181150	Signaling by NODAL	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-1221632	Meiotic synapsis	 22	0.0899037756917286	1	6	16	565	3320	1.86610412354721
R-HSA-1222556	ROS, RNS production in phagocytes	 17	0.462173416449949	1	3	14	568	3322	1.20747913876584
R-HSA-1226099	Signaling by FGFR in disease	 33	0.349808620649348	1	6	27	565	3309	1.24406941569814
R-HSA-1227986	Signaling by ERBB2	 25	0.729986805349405	1	3	22	568	3314	0.821085814360771
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	  6	0.0440755673312621	1	3	3	568	3333	3.42119089316988
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	 20	0.576655301532624	1	3	17	568	3319	1.02635726795096
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-1236394	Signaling by ERBB4	 25	0.297618773070469	1	5	20	566	3316	1.36847635726795
R-HSA-1236974	ER-Phagosome pathway	 36	0.914230643624875	1	3	33	568	3303	0.57019848219498
R-HSA-1236975	Antigen processing-Cross presentation	 43	0.961739001353323	1	3	40	568	3296	0.477375473465564
R-HSA-1236977	Endosomal/Vacuolar pathway	  5	1	1	0	5	571	3331	0
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	  8	1	1	0	8	571	3328	0
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	  5	1	1	0	5	571	3331	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-1250342	PI3K events in ERBB4 signaling	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-1250347	SHC1 events in ERBB4 signaling	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-1251985	Nuclear signaling by ERBB4	 14	0.0420618470870275	1	5	9	566	3327	2.44370778083563
R-HSA-1266695	Interleukin-7 signaling	 16	0.920597828991936	1	1	15	570	3321	0.427648861646235
R-HSA-1268020	Mitochondrial protein import	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-1295596	Spry regulation of FGF signaling	  8	0.0986415063991545	1	3	5	568	3331	2.56589316987741
R-HSA-1296041	Activation of G protein gated Potassium channels	 13	1	1	0	13	571	3323	0
R-HSA-1296052	Ca2+ activated K+ channels	  6	1	1	0	6	571	3330	0
R-HSA-1296059	G protein gated Potassium channels	 13	1	1	0	13	571	3323	0
R-HSA-1296065	Inwardly rectifying K+ channels	 15	0.906945724310935	1	1	14	570	3322	0.456158785755984
R-HSA-1296071	Potassium Channels	 45	0.993113965180595	1	2	43	569	3293	0.304105857170656
R-HSA-1296072	Voltage gated Potassium channels	 19	0.950682015525071	1	1	18	570	3318	0.360125357175777
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-1368082	RORA activates gene expression	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	 30	0.657981025406859	1	4	26	567	3310	0.912317571511967
R-HSA-1369062	ABC transporters in lipid homeostasis	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-139853	Elevation of cytosolic Ca2+ levels	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-140342	Apoptosis induced DNA fragmentation	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-140534	Ligand-dependent caspase activation	  7	1	1	0	7	571	3329	0
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-140875	Common Pathway of Fibrin Clot Formation	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-141424	Amplification of signal from the kinetochores	 37	0.290971977743772	1	7	30	564	3306	1.29450466228049
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	 37	0.290971977743772	1	7	30	564	3306	1.29450466228049
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	 73	1.82485995946541e-05	0.0111225214529417	25	48	546	3288	2.343281433678
R-HSA-1433557	Signaling by SCF-KIT	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-1433559	Regulation of KIT signaling	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-1442490	Collagen degradation	 25	0.729986805349405	1	3	22	568	3314	0.821085814360771
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	 45	0.912318009902936	1	4	41	567	3295	0.608211714341312
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-1474165	Reproduction	 32	0.176497733265409	1	7	25	564	3311	1.49677101576182
R-HSA-1474228	Degradation of the extracellular matrix	 47	0.976347776693686	1	3	44	568	3292	0.436747773596155
R-HSA-1474290	Collagen formation	 39	0.842769869773058	1	4	35	567	3301	0.701782747316898
R-HSA-1475029	Reversible hydration of carbon dioxide	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-1480926	O2/CO2 exchange in erythrocytes	  8	1	1	0	8	571	3328	0
R-HSA-1482788	Acyl chain remodelling of PC	  8	1	1	0	8	571	3328	0
R-HSA-1482801	Acyl chain remodelling of PS	  8	1	1	0	8	571	3328	0
R-HSA-1482839	Acyl chain remodelling of PE	  9	1	1	0	9	571	3327	0
R-HSA-1482922	Acyl chain remodelling of PI	  6	1	1	0	6	571	3330	0
R-HSA-1482925	Acyl chain remodelling of PG	  6	1	1	0	6	571	3330	0
R-HSA-1483166	Synthesis of PA	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-1483191	Synthesis of PC	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-1483206	Glycerophospholipid biosynthesis	 52	0.497263262792233	1	8	44	563	3292	1.05267412097535
R-HSA-1483213	Synthesis of PE	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-1483249	Inositol phosphate metabolism	 28	0.601598527359927	1	4	24	567	3312	0.977483112334251
R-HSA-1483255	PI Metabolism	 43	0.442813871192955	1	7	36	564	3300	1.11387610475298
R-HSA-1483257	Phospholipid metabolism	 94	0.514684199105548	1	14	80	557	3256	1.01907813839103
R-HSA-1489509	DAG and IP3 signaling	 23	0.674594141757564	1	3	20	568	3316	0.892484580826925
R-HSA-1500620	Meiosis	 28	0.102837157114125	1	7	21	564	3315	1.71059544658494
R-HSA-1500931	Cell-Cell communication	 45	0.993113965180595	1	2	43	569	3293	0.304105857170656
R-HSA-1502540	Signaling by Activin	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-1538133	G0 and Early G1	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-156580	Phase II - Conjugation of compounds	 30	0.137241871318607	1	7	23	564	3313	1.59655575014594
R-HSA-156584	Cytosolic sulfonation of small molecules	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-156590	Glutathione conjugation	 17	0.0898839523961524	1	5	12	566	3324	2.0124652312764
R-HSA-1566948	Elastic fibre formation	 18	1	1	0	18	571	3318	0
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	 16	0.920597828991936	1	1	15	570	3321	0.427648861646235
R-HSA-156842	Eukaryotic Translation Elongation	  8	1	1	0	8	571	3328	0
R-HSA-156902	Peptide chain elongation	  7	1	1	0	7	571	3329	0
R-HSA-157118	Signaling by NOTCH	 54	0.0433094422381612	1	13	41	558	3295	1.64724005967439
R-HSA-157579	Telomere Maintenance	 19	0.540178666327839	1	3	16	568	3320	1.08037607152733
R-HSA-157858	Gap junction trafficking and regulation	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-15869	Metabolism of nucleotides	 43	0.774431278989192	1	5	38	566	3298	0.795625789109274
R-HSA-1592230	Mitochondrial biogenesis	 45	0.0547092723922765	1	11	34	560	3302	1.67258221443861
R-HSA-159227	Transport of the SLBP independent Mature mRNA	 21	0.834308558457058	1	2	19	569	3317	0.651655408222834
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	 21	0.834308558457058	1	2	19	569	3317	0.651655408222834
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	 24	0.885561933608418	1	2	22	569	3314	0.57019848219498
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	 24	0.885561933608418	1	2	22	569	3314	0.57019848219498
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	 36	0.621676781566321	1	5	31	566	3305	0.950330803658299
R-HSA-1592389	Activation of Matrix Metalloproteinases	  8	1	1	0	8	571	3328	0
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	  9	1	1	0	9	571	3327	0
R-HSA-1614558	Degradation of cysteine and homocysteine	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-1614635	Sulfur amino acid metabolism	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-162587	HIV Life Cycle	 68	0.408061741887447	1	11	57	560	3279	1.10685587720202
R-HSA-162588	Budding and maturation of HIV virion	 13	1	1	0	13	571	3323	0
R-HSA-162592	Integration of provirus	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-162594	Early Phase of HIV Life Cycle	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-162599	Late Phase of HIV Life Cycle	 61	0.543673822930164	1	9	52	562	3284	1.00953173896816
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-162909	Host Interactions of HIV factors	 62	0.822156798329457	1	7	55	564	3281	0.772526975877069
R-HSA-1630316	Glycosaminoglycan metabolism	 49	0.426980514651638	1	8	41	563	3295	1.11712355695343
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	 31	0.992689213727499	1	1	30	570	3306	0.220721993107734
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	 44	1.77833698183783e-05	0.0111225214529417	18	26	553	3310	2.79915618532081
R-HSA-163210	Formation of ATP by chemiosmotic coupling	  8	0.00250297473548007	0.305112620255021	5	3	566	3333	4.27648861646235
R-HSA-1632852	Macroautophagy	 30	0.947016579809796	1	2	28	569	3308	0.456158785755984
R-HSA-163359	Glucagon signaling in metabolic regulation	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-163560	Triglyceride catabolism	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-163615	PKA activation	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-163685	Integration of energy metabolism	 58	0.337421031747764	1	10	48	561	3288	1.17972099764479
R-HSA-1638074	Keratan sulfate/keratin metabolism	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	 24	0.473826708399727	1	4	20	567	3316	1.14039696438996
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-1643713	Signaling by EGFR in Cancer	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-164378	PKA activation in glucagon signalling	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	 11	1	1	0	11	571	3325	0
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	  5	1	1	0	5	571	3331	0
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	 14	1	1	0	14	571	3322	0
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	 31	0.852343334536178	1	3	28	568	3308	0.662165979323202
R-HSA-165159	mTOR signalling	 16	0.920597828991936	1	1	15	570	3321	0.427648861646235
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	 37	0.0136584454826689	1	11	26	560	3310	2.03422161215506
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	 64	0.329014464901424	1	11	53	560	3283	1.17603436952715
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	 27	0.777694768992292	1	3	24	568	3312	0.760264642926639
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-166054	Activated TLR4 signalling	 58	0.337421031747764	1	10	48	561	3288	1.17972099764479
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	 53	0.238633102264341	1	10	43	561	3293	1.29101543138486
R-HSA-1660661	Sphingolipid de novo biosynthesis	 24	0.977720320035534	1	1	23	570	3313	0.28509924109749
R-HSA-1660662	Glycosphingolipid metabolism	 15	0.055752373781686	1	5	10	566	3326	2.28079392877992
R-HSA-166166	MyD88-independent TLR4 cascade 	 54	0.257557061740381	1	10	44	561	3292	1.26710773821107
R-HSA-166208	mTORC1-mediated signalling	  8	1	1	0	8	571	3328	0
R-HSA-166520	Signalling by NGF	100	0.200998289731903	1	18	82	553	3254	1.23162872154116
R-HSA-166658	Complement cascade	 17	1	1	0	17	571	3319	0
R-HSA-166663	Initial triggering of complement	  7	1	1	0	7	571	3329	0
R-HSA-166786	Creation of C4 and C2 activators	  5	1	1	0	5	571	3331	0
R-HSA-167044	Signalling to RAS	  9	1	1	0	9	571	3327	0
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	 17	0.0280800047348313	1	6	11	565	3325	2.41495827753168
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	 14	0.0420618470870275	1	5	9	566	3327	2.44370778083563
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	 12	0.0213502171580283	1	5	7	566	3329	2.8509924109749
R-HSA-167161	HIV Transcription Initiation	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-167169	HIV Transcription Elongation	 16	0.071706320731058	1	5	11	566	3325	2.13824430823117
R-HSA-167172	Transcription of the HIV genome	 25	0.146970553330286	1	6	19	565	3317	1.64217162872154
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	 16	0.071706320731058	1	5	11	566	3325	2.13824430823117
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	  8	1	1	0	8	571	3328	0
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	  8	1	1	0	8	571	3328	0
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	  8	1	1	0	8	571	3328	0
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	 16	0.071706320731058	1	5	11	566	3325	2.13824430823117
R-HSA-167287	HIV elongation arrest and recovery	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-167290	Pausing and recovery of HIV elongation	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-167590	Nef Mediated CD4 Down-regulation	  6	1	1	0	6	571	3330	0
R-HSA-1679131	Trafficking and processing of endosomal TLR	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	 56	0.185788054099883	1	11	45	560	3291	1.34403927945959
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	 49	0.091825723047435	1	11	38	560	3298	1.53604489081097
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	 53	0.238633102264341	1	10	43	561	3293	1.29101543138486
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	 49	0.091825723047435	1	11	38	560	3298	1.53604489081097
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	 53	0.238633102264341	1	10	43	561	3293	1.29101543138486
R-HSA-168180	TRAF6 Mediated Induction of proinflammatory cytokines	 49	0.168847754987541	1	10	39	561	3297	1.39640444619179
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	 54	0.155367680569759	1	11	43	560	3293	1.39381851203217
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	 53	0.238633102264341	1	10	43	561	3293	1.29101543138486
R-HSA-168253	Host Interactions with Influenza Factors	 23	0.439437111853512	1	4	19	567	3317	1.18997944110257
R-HSA-168254	Influenza Infection	 44	0.468064813852353	1	7	37	564	3299	1.08856073873587
R-HSA-168255	Influenza Life Cycle	 40	0.540978675534585	1	6	34	565	3302	1.02635726795096
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	 19	0.540178666327839	1	3	16	568	3320	1.08037607152733
R-HSA-168273	Influenza Viral RNA Transcription and Replication	 32	0.867199935487935	1	3	29	568	3307	0.641473292469352
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	 20	0.813066065533173	1	2	18	569	3318	0.684238178633976
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	 22	0.404421397552873	1	4	18	567	3318	1.24406941569814
R-HSA-168325	Viral Messenger RNA Synthesis	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-168638	NOD1/2 Signaling Pathway	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	 22	0.643921485683122	1	3	19	568	3317	0.933052061773603
R-HSA-168799	Neurotoxicity of clostridium toxins	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-168898	Toll-Like Receptors Cascades	 77	0.226808396331543	1	14	63	557	3273	1.24406941569814
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment 	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	 34	0.753770048806174	1	4	30	567	3306	0.804986092510559
R-HSA-169893	Prolonged ERK activation events	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-169911	Regulation of Apoptosis	 18	0.501957999230575	1	3	15	568	3321	1.14039696438996
R-HSA-170660	Adenylate cyclase activating pathway	  6	1	1	0	6	571	3330	0
R-HSA-170670	Adenylate cyclase inhibitory pathway	  8	1	1	0	8	571	3328	0
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-170834	Signaling by TGF-beta Receptor Complex	 43	0.16637608360423	1	9	34	562	3302	1.43212642039669
R-HSA-170968	Frs2-mediated activation	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-171007	p38MAPK events	  6	1	1	0	6	571	3330	0
R-HSA-171306	Packaging Of Telomere Ends	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-173623	Classical antibody-mediated complement activation	  5	1	1	0	5	571	3331	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	 23	0.674594141757564	1	3	20	568	3316	0.892484580826925
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	 18	0.501957999230575	1	3	15	568	3321	1.14039696438996
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	 28	0.601598527359927	1	4	24	567	3312	0.977483112334251
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	 24	0.703275203665827	1	3	21	568	3315	0.855297723292469
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	 24	0.703275203665827	1	3	21	568	3315	0.855297723292469
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	 26	0.75477295546795	1	3	23	568	3313	0.78950559073151
R-HSA-174403	Glutathione synthesis and recycling	  7	0.0689222844016876	1	3	4	568	3332	2.93244933700275
R-HSA-174411	Polymerase switching on the C-strand of the telomere	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-174490	Membrane binding and targetting of GAG proteins	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	 28	0.931249168083512	1	2	26	569	3310	0.488741556167125
R-HSA-175474	Assembly Of The HIV Virion	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-176033	Interactions of Vpr with host cellular proteins	 21	0.61126238275627	1	3	18	568	3318	0.977483112334251
R-HSA-176187	Activation of ATR in response to replication stress	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	 28	0.601598527359927	1	4	24	567	3312	0.977483112334251
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	 26	0.75477295546795	1	3	23	568	3313	0.78950559073151
R-HSA-176412	Phosphorylation of the APC/C	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	 26	0.75477295546795	1	3	23	568	3313	0.78950559073151
R-HSA-177243	Interactions of Rev with host cellular proteins	 23	0.674594141757564	1	3	20	568	3316	0.892484580826925
R-HSA-177504	Retrograde neurotrophin signalling	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-177929	Signaling by EGFR	 24	0.977720320035534	1	1	23	570	3313	0.28509924109749
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	 20	0.156661272889579	1	5	15	566	3321	1.71059544658494
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	 26	0.75477295546795	1	3	23	568	3313	0.78950559073151
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	 19	0.540178666327839	1	3	16	568	3320	1.08037607152733
R-HSA-180024	DARPP-32 events	 19	0.298114441378495	1	4	15	567	3321	1.44050142870311
R-HSA-180292	GAB1 signalosome	  6	1	1	0	6	571	3330	0
R-HSA-180336	SHC1 events in EGFR signaling	  5	1	1	0	5	571	3331	0
R-HSA-180534	Vpu mediated degradation of CD4	 17	0.462173416449949	1	3	14	568	3322	1.20747913876584
R-HSA-180585	Vif-mediated degradation of APOBEC3G	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-180746	Nuclear import of Rev protein	 20	0.576655301532624	1	3	17	568	3319	1.02635726795096
R-HSA-180786	Extension of Telomeres	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-180910	Vpr-mediated nuclear import of PICs	 20	0.813066065533173	1	2	18	569	3318	0.684238178633976
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	  9	1	1	0	9	571	3327	0
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	 53	0.238633102264341	1	10	43	561	3293	1.29101543138486
R-HSA-182218	Nef Mediated CD8 Down-regulation	  6	1	1	0	6	571	3330	0
R-HSA-182971	EGFR downregulation	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	 31	0.294847569944065	1	6	25	565	3311	1.3243319586464
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	 13	0.109203722146622	1	4	9	567	3327	2.10534824195069
R-HSA-1839124	FGFR1 mutant receptor activation	 19	0.132510731928056	1	5	14	566	3322	1.80062678587888
R-HSA-1839126	FGFR2 mutant receptor activation	 11	1	1	0	11	571	3325	0
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	  6	1	1	0	6	571	3330	0
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-186712	Regulation of beta-cell development	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-186763	Downstream signal transduction	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-186797	Signaling by PDGF	 30	0.947016579809796	1	2	28	569	3308	0.456158785755984
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	 53	0.238633102264341	1	10	43	561	3293	1.29101543138486
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	 21	0.369012814190748	1	4	17	567	3319	1.30331081644567
R-HSA-187687	Signalling to ERKs	 17	0.932250010859221	1	1	16	570	3320	0.40249304625528
R-HSA-189200	Cellular hexose transport	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-189445	Metabolism of porphyrins	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-189451	Heme biosynthesis	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-190236	Signaling by FGFR	 42	0.417372879155402	1	7	35	564	3301	1.14039696438996
R-HSA-190241	FGFR2 ligand binding and activation	  5	1	1	0	5	571	3331	0
R-HSA-190242	FGFR1 ligand binding and activation	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-190373	FGFR1c ligand binding and activation	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-190828	Gap junction trafficking	 21	0.834308558457058	1	2	19	569	3317	0.651655408222834
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	  8	1	1	0	8	571	3328	0
R-HSA-190861	Gap junction assembly	 13	1	1	0	13	571	3323	0
R-HSA-190872	Transport of connexons to the plasma membrane	  9	1	1	0	9	571	3327	0
R-HSA-190873	Gap junction degradation	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-1912408	Pre-NOTCH Transcription and Translation	 18	0.0370725585590749	1	6	12	565	3324	2.28079392877992
R-HSA-1912420	Pre-NOTCH Processing in Golgi	  7	0.0689222844016876	1	3	4	568	3332	2.93244933700275
R-HSA-1912422	Pre-NOTCH Expression and Processing	 24	0.0168340085020492	1	8	16	563	3320	2.28079392877992
R-HSA-191273	Cholesterol biosynthesis	 16	0.071706320731058	1	5	11	566	3325	2.13824430823117
R-HSA-191859	snRNP Assembly	 25	0.507390124652919	1	4	21	567	3315	1.09478108581436
R-HSA-192105	Synthesis of bile acids and bile salts	 14	0.890951145316818	1	1	13	570	3323	0.488741556167125
R-HSA-192823	Viral mRNA Translation	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	  6	1	1	0	6	571	3330	0
R-HSA-193634	Axonal growth inhibition (RHOA activation)	  5	1	1	0	5	571	3331	0
R-HSA-193639	p75NTR signals via NF-kB	  7	1	1	0	7	571	3329	0
R-HSA-193648	NRAGE signals death through JNK	 28	0.216534288591796	1	6	22	565	3314	1.46622466850138
R-HSA-193697	p75NTR regulates axonogenesis	  5	1	1	0	5	571	3331	0
R-HSA-193704	p75 NTR receptor-mediated signalling	 46	0.517637135921528	1	7	39	564	3297	1.04123201096475
R-HSA-194068	Bile acid and bile salt metabolism	 15	0.906945724310935	1	1	14	570	3322	0.456158785755984
R-HSA-194138	Signaling by VEGF	 55	0.712566361645566	1	7	48	564	3288	0.870848590988696
R-HSA-194441	Metabolism of non-coding RNA	 25	0.507390124652919	1	4	21	567	3315	1.09478108581436
R-HSA-194840	Rho GTPase cycle	 64	0.604928086689864	1	9	55	562	3281	0.962209938704028
R-HSA-195253	Degradation of beta-catenin by the destruction complex	 38	0.0921524282602915	1	9	29	562	3307	1.62056410729099
R-HSA-196025	Formation of annular gap junctions	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-196071	Metabolism of steroid hormones	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-196299	Beta-catenin phosphorylation cascade	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-1963640	GRB2 events in ERBB2 signaling	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-1963642	PI3K events in ERBB2 signaling	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	  8	1	1	0	8	571	3328	0
R-HSA-196757	Metabolism of folate and pterines	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-196780	Biotin transport and metabolism	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-196807	Nicotinate metabolism	 14	1	1	0	14	571	3322	0
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	 51	0.324540826796877	1	9	42	562	3294	1.20747913876584
R-HSA-196854	Metabolism of vitamins and cofactors	 71	0.602870837139017	1	10	61	561	3275	0.963715744554895
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-197264	Nicotinamide salvaging	  8	1	1	0	8	571	3328	0
R-HSA-1980143	Signaling by NOTCH1	 35	0.24292461052891	1	7	28	564	3308	1.36847635726795
R-HSA-1980145	Signaling by NOTCH2	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-1980148	Signaling by NOTCH3	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-1980150	Signaling by NOTCH4	  5	1	1	0	5	571	3331	0
R-HSA-198203	PI3K/AKT activation	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-198323	AKT phosphorylates targets in the cytosol	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-198693	AKT phosphorylates targets in the nucleus	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	 19	0.132510731928056	1	5	14	566	3322	1.80062678587888
R-HSA-198753	ERK/MAPK targets	 17	0.0898839523961524	1	5	12	566	3324	2.0124652312764
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	 34	0.995468217351404	1	1	33	570	3303	0.20124652312764
R-HSA-1989781	PPARA activates gene expression	 58	0.21871361919574	1	11	47	560	3289	1.29769309740926
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-199418	Negative regulation of the PI3K/AKT network	 48	0.261062744931084	1	9	39	562	3297	1.2829465849387
R-HSA-199920	CREB phosphorylation	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-199977	ER to Golgi Anterograde Transport	 69	0.896100689390885	1	7	62	564	3274	0.694154673976497
R-HSA-199992	trans-Golgi Network Vesicle Budding	 40	0.986212290228923	1	2	38	569	3298	0.342119089316988
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	  7	1	1	0	7	571	3329	0
R-HSA-201451	Signaling by BMP	 16	0.0206536904930676	1	6	10	565	3326	2.56589316987741
R-HSA-201681	TCF dependent signaling in response to WNT	 82	0.209394211461311	1	15	67	556	3269	1.25165520481825
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	 25	0.297618773070469	1	5	20	566	3316	1.36847635726795
R-HSA-202040	G-protein activation	 11	1	1	0	11	571	3325	0
R-HSA-202131	Metabolism of nitric oxide	 15	0.165263417039104	1	4	11	567	3325	1.82463514302393
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	 26	0.75477295546795	1	3	23	568	3313	0.78950559073151
R-HSA-2022854	Keratan sulfate biosynthesis	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-2022870	Chondroitin sulfate biosynthesis	 10	0.169677539283834	1	3	7	568	3329	2.05271453590193
R-HSA-2022923	Dermatan sulfate biosynthesis	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-2022928	HS-GAG biosynthesis	 14	1	1	0	14	571	3322	0
R-HSA-202403	TCR signaling	 43	0.442813871192955	1	7	36	564	3300	1.11387610475298
R-HSA-2024096	HS-GAG degradation	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-2024101	CS/DS degradation	  6	0.0440755673312621	1	3	3	568	3333	3.42119089316988
R-HSA-202424	Downstream TCR signaling	 36	0.433288922899037	1	6	30	565	3306	1.14039696438996
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-202433	Generation of second messenger molecules	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-2025928	Calcineurin activates NFAT	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-202670	ERKs are inactivated	  9	0.132494538278632	1	3	6	568	3330	2.28079392877992
R-HSA-202733	Cell surface interactions at the vascular wall	 64	0.999962874321168	1	1	63	570	3273	0.106912215411559
R-HSA-2028269	Signaling by Hippo	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	 44	0.63878329697613	1	6	38	565	3298	0.933052061773603
R-HSA-2029481	FCGR activation	  5	1	1	0	5	571	3331	0
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	 26	0.32825771082092	1	5	21	566	3315	1.31584265121918
R-HSA-2029485	Role of phospholipids in phagocytosis	 15	0.906945724310935	1	1	14	570	3322	0.456158785755984
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	 18	0.263250502546824	1	4	14	567	3322	1.52052928585328
R-HSA-203615	eNOS activation	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-203765	eNOS activation and regulation	 15	0.165263417039104	1	4	11	567	3325	1.82463514302393
R-HSA-203927	MicroRNA (miRNA) biogenesis	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	 35	0.774190467852666	1	4	31	567	3305	0.781986489867401
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	 35	0.24292461052891	1	7	28	564	3308	1.36847635726795
R-HSA-205043	NRIF signals cell death from the nucleus	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-209543	p75NTR recruits signalling complexes	  6	1	1	0	6	571	3330	0
R-HSA-209560	NF-kB is activated and signals survival	  5	1	1	0	5	571	3331	0
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	 22	0.643921485683122	1	3	19	568	3317	0.933052061773603
R-HSA-210745	Regulation of gene expression in beta cells	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-210991	Basigin interactions	 16	1	1	0	16	571	3320	0
R-HSA-210993	Tie2 Signaling	 11	1	1	0	11	571	3325	0
R-HSA-211000	Gene Silencing by RNA	 48	0.851070592109651	1	5	43	566	3293	0.712748102743724
R-HSA-211227	Activation of DNA fragmentation factor	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-211859	Biological oxidations	 61	0.272068260872874	1	11	50	560	3286	1.23387212540553
R-HSA-211897	Cytochrome P450 - arranged by substrate type	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-211945	Phase I - Functionalization of compounds	 30	0.657981025406859	1	4	26	567	3310	0.912317571511967
R-HSA-211976	Endogenous sterols	  7	1	1	0	7	571	3329	0
R-HSA-212165	Epigenetic regulation of gene expression	 48	0.0813978506398063	1	11	37	560	3299	1.56804582603619
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	 23	0.238096754624837	1	5	18	566	3318	1.48747430137821
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-212300	PRC2 methylates histones and DNA	 12	1	1	0	12	571	3324	0
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-2129379	Molecules associated with elastic fibres	 17	1	1	0	17	571	3319	0
R-HSA-2132295	MHC class II antigen presentation	 61	0.686046186453084	1	8	53	563	3283	0.897361545749476
R-HSA-2142753	Arachidonic acid metabolism	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-2142845	Hyaluronan metabolism	  5	1	1	0	5	571	3331	0
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	 28	0.390197966752957	1	5	23	566	3313	1.22185389041781
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	  6	1	1	0	6	571	3330	0
R-HSA-216083	Integrin cell surface interactions	 39	0.997959564548551	1	1	38	570	3298	0.175445686829224
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-2172127	DAP12 interactions	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	 20	1	1	0	20	571	3316	0
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	 20	0.333477733500725	1	4	16	567	3320	1.36847635726795
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	  7	1	1	0	7	571	3329	0
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	 27	0.03416510793719	1	8	19	563	3317	2.02737238113771
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	 17	0.0280800047348313	1	6	11	565	3325	2.41495827753168
R-HSA-2179392	EGFR Transactivation by Gastrin	  5	1	1	0	5	571	3331	0
R-HSA-2187338	Visual phototransduction	 34	0.753770048806174	1	4	30	567	3306	0.804986092510559
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-2214320	Anchoring fibril formation	  6	1	1	0	6	571	3330	0
R-HSA-2219528	PI3K/AKT Signaling in Cancer	 38	0.181147845648135	1	8	30	563	3306	1.44050142870311
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	 27	0.359186595652749	1	5	22	566	3314	1.26710773821107
R-HSA-2243919	Crosslinking of collagen fibrils	  8	1	1	0	8	571	3328	0
R-HSA-2262749	Cellular response to hypoxia	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-2299718	Condensation of Prophase Chromosomes	 11	1	1	0	11	571	3325	0
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	 25	0.297618773070469	1	5	20	566	3316	1.36847635726795
R-HSA-2408517	SeMet incorporation into proteins	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-2408522	Selenoamino acid metabolism	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-2408557	Selenocysteine synthesis	  8	1	1	0	8	571	3328	0
R-HSA-2424491	DAP12 signaling	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	 28	0.0044864910663617	0.49718478271772	10	18	561	3318	2.44370778083563
R-HSA-2428924	IGF1R signaling cascade	 25	0.297618773070469	1	5	20	566	3316	1.36847635726795
R-HSA-2428928	IRS-related events triggered by IGF1R	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-2428933	SHC-related events triggered by IGF1R	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-2453864	Retinoid cycle disease events	  5	1	1	0	5	571	3331	0
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	 10	1	1	0	10	571	3326	0
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	 58	0.337421031747764	1	10	48	561	3288	1.17972099764479
R-HSA-2465910	MASTL Facilitates Mitotic Progression	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-2467813	Separation of Sister Chromatids	 76	0.434286951379815	1	12	64	559	3272	1.08037607152733
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-2470946	Cohesin Loading onto Chromatin	 10	0.169677539283834	1	3	7	568	3329	2.05271453590193
R-HSA-2474795	Diseases associated with visual transduction	  5	1	1	0	5	571	3331	0
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	 52	0.346369936754006	1	9	43	562	3293	1.18425838609727
R-HSA-2514856	The phototransduction cascade	  9	0.132494538278632	1	3	6	568	3330	2.28079392877992
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	  9	0.132494538278632	1	3	6	568	3330	2.28079392877992
R-HSA-2555396	Mitotic Metaphase and Anaphase	 79	0.491154978979009	1	12	67	559	3269	1.03934913210224
R-HSA-2559580	Oxidative Stress Induced Senescence	 38	0.8274928526084	1	4	34	567	3302	0.720250714351553
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	 33	0.964371709729202	1	2	31	569	3305	0.414689805232712
R-HSA-2559583	Cellular Senescence	 70	0.713705571793344	1	9	61	562	3275	0.879734801100826
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-2559585	Oncogene Induced Senescence	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	 20	0.813066065533173	1	2	18	569	3318	0.684238178633976
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	 45	0.912318009902936	1	4	41	567	3295	0.608211714341312
R-HSA-2586552	Signaling by Leptin	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	 31	0.481878271343823	1	5	26	566	3310	1.10360996553867
R-HSA-2644603	Signaling by NOTCH1 in Cancer	 31	0.481878271343823	1	5	26	566	3310	1.10360996553867
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	 31	0.481878271343823	1	5	26	566	3310	1.10360996553867
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-264876	Insulin processing	 24	0.703275203665827	1	3	21	568	3315	0.855297723292469
R-HSA-2672351	Stimuli-sensing channels	 40	0.856893935560437	1	4	36	567	3300	0.684238178633976
R-HSA-2682334	EPH-Ephrin signaling	 44	0.903058543984485	1	4	40	567	3296	0.622034707849069
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	  6	1	1	0	6	571	3330	0
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	  6	1	1	0	6	571	3330	0
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	 10	1	1	0	10	571	3326	0
R-HSA-2871796	FCERI mediated MAPK activation	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-2871809	FCERI mediated Ca+2 mobilization	 14	0.336213754518406	1	3	11	568	3325	1.46622466850138
R-HSA-2871837	FCERI mediated NF-kB activation	 32	0.511455901089704	1	5	27	566	3309	1.06912215411559
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	 31	0.481878271343823	1	5	26	566	3310	1.10360996553867
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	 31	0.481878271343823	1	5	26	566	3310	1.10360996553867
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-2980736	Peptide hormone metabolism	 39	0.693818952417639	1	5	34	566	3302	0.877228434146123
R-HSA-2980766	Nuclear Envelope Breakdown	 25	0.899090205630941	1	2	23	569	3313	0.54739054290718
R-HSA-2990846	SUMOylation	 52	0.497263262792233	1	8	44	563	3292	1.05267412097535
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-2995410	Nuclear Envelope Reassembly	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-3000157	Laminin interactions	 13	1	1	0	13	571	3323	0
R-HSA-3000170	Syndecan interactions	 19	1	1	0	19	571	3317	0
R-HSA-3000171	Non-integrin membrane-ECM interactions	 30	0.947016579809796	1	2	28	569	3308	0.456158785755984
R-HSA-3000178	ECM proteoglycans	 36	0.914230643624875	1	3	33	568	3303	0.57019848219498
R-HSA-3000480	Scavenging by Class A Receptors	 12	1	1	0	12	571	3324	0
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	 37	0.646808444609437	1	5	32	566	3304	0.92464618734321
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	 51	0.474048904940198	1	8	43	563	3293	1.07331479001408
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-3214815	HDACs deacetylate histones	 24	0.977720320035534	1	1	23	570	3313	0.28509924109749
R-HSA-3214841	PKMTs methylate histone lysines	 17	0.229238396858391	1	4	13	567	3323	1.60997218502112
R-HSA-3214842	HDMs demethylate histones	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-3214847	HATs acetylate histones	 40	0.221208589803675	1	8	32	563	3304	1.36847635726795
R-HSA-3214858	RMTs methylate histone arginines	 17	0.229238396858391	1	4	13	567	3323	1.60997218502112
R-HSA-3232118	SUMOylation of transcription factors	  9	0.132494538278632	1	3	6	568	3330	2.28079392877992
R-HSA-3247509	Chromatin modifying enzymes	 97	0.106841324381525	1	19	78	552	3258	1.3402603499016
R-HSA-3295583	TRP channels	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-3296469	Defects in cobalamin (B12) metabolism	  6	1	1	0	6	571	3330	0
R-HSA-3296482	Defects in vitamin and cofactor metabolism	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-3299685	Detoxification of Reactive Oxygen Species	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	 20	0.813066065533173	1	2	18	569	3318	0.684238178633976
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	 51	0.632762670680351	1	7	44	564	3292	0.939150441262319
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	 32	0.959302158049083	1	2	30	569	3306	0.427648861646235
R-HSA-3371511	HSF1 activation	 20	0.813066065533173	1	2	18	569	3318	0.684238178633976
R-HSA-3371556	Cellular response to heat stress	 65	0.348549792808284	1	11	54	560	3282	1.15794153307288
R-HSA-3371568	Attenuation phase	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-3371571	HSF1-dependent transactivation	 24	0.703275203665827	1	3	21	568	3315	0.855297723292469
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-350054	Notch-HLH transcription pathway	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-351202	Metabolism of polyamines	 32	0.867199935487935	1	3	29	568	3307	0.641473292469352
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	  5	1	1	0	5	571	3331	0
R-HSA-352230	Amino acid transport across the plasma membrane	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-354192	Integrin alphaIIb beta3 signaling	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	  7	1	1	0	7	571	3329	0
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	 18	0.263250502546824	1	4	14	567	3322	1.52052928585328
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-3595172	Defective CHST3 causes SEDCJD	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-3595177	Defective CHSY1 causes TPBS	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-3656225	Defective CHST6 causes MCDC1	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	  5	1	1	0	5	571	3331	0
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	  5	1	1	0	5	571	3331	0
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	  6	1	1	0	6	571	3330	0
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	 75	0.989988967855753	1	5	70	566	3266	0.456158785755984
R-HSA-373080	Class B/2 (Secretin family receptors)	 26	0.75477295546795	1	3	23	568	3313	0.78950559073151
R-HSA-373752	Netrin-1 signaling	 27	0.359186595652749	1	5	22	566	3314	1.26710773821107
R-HSA-373753	Nephrin family interactions	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-373755	Semaphorin interactions	 29	0.989946190561354	1	1	28	570	3308	0.235944199528957
R-HSA-373760	L1CAM interactions	 65	0.624424652885497	1	9	56	562	3280	0.947406708877812
R-HSA-375165	NCAM signaling for neurite out-growth	 34	0.753770048806174	1	4	30	567	3306	0.804986092510559
R-HSA-375170	CDO in myogenesis	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-375276	Peptide ligand-binding receptors	 44	0.966032693355921	1	3	41	568	3295	0.466526030886802
R-HSA-375280	Amine ligand-binding receptors	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-376176	Signaling by ROBO receptors	 60	0.951346360759952	1	5	55	566	3281	0.57019848219498
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	 17	0.229238396858391	1	4	13	567	3323	1.60997218502112
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	  6	1	1	0	6	571	3330	0
R-HSA-3781860	Diseases associated with N-glycosylation of proteins	  5	1	1	0	5	571	3331	0
R-HSA-3781865	Diseases of glycosylation	 41	0.242373264711943	1	8	33	563	3303	1.33509888513946
R-HSA-379716	Cytosolic tRNA aminoacylation	 13	0.293323765443846	1	3	10	568	3326	1.57901118146302
R-HSA-379724	tRNA Aminoacylation	 21	0.369012814190748	1	4	17	567	3319	1.30331081644567
R-HSA-379726	Mitochondrial tRNA aminoacylation	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-380108	Chemokine receptors bind chemokines	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-380259	Loss of Nlp from mitotic centrosomes	 38	0.931554083964144	1	3	35	568	3301	0.540188035763665
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	 45	0.661206266662592	1	6	39	565	3297	0.912317571511967
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	 38	0.931554083964144	1	3	35	568	3301	0.540188035763665
R-HSA-380287	Centrosome maturation	 45	0.661206266662592	1	6	39	565	3297	0.912317571511967
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	 49	0.741844276176443	1	6	43	565	3293	0.837842667715072
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	 12	1	1	0	12	571	3324	0
R-HSA-380994	ATF4 activates genes	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	  5	1	1	0	5	571	3331	0
R-HSA-381038	XBP1(S) activates chaperone genes	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-381042	PERK regulates gene expression	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-381070	IRE1alpha activates chaperones	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-381119	Unfolded Protein Response (UPR)	 42	0.264178624942172	1	8	34	563	3302	1.30331081644567
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	 45	0.332517835831291	1	8	37	563	3299	1.21642342868262
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	 48	0.851070592109651	1	5	43	566	3293	0.712748102743724
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	 24	0.473826708399727	1	4	20	567	3316	1.14039696438996
R-HSA-381753	Olfactory Signaling Pathway	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-382556	ABC-family proteins mediated transport	 34	0.377642973330823	1	6	28	565	3308	1.20747913876584
R-HSA-383280	Nuclear Receptor transcription pathway	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-3858494	Beta-catenin independent WNT signaling	 67	0.267191743879207	1	12	55	559	3281	1.22550121546384
R-HSA-388841	Costimulation by the CD28 family	 28	0.390197966752957	1	5	23	566	3313	1.22185389041781
R-HSA-388844	Receptor-type tyrosine-protein phosphatases	 14	0.336213754518406	1	3	11	568	3325	1.46622466850138
R-HSA-389356	CD28 co-stimulation	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-389357	CD28 dependent PI3K/Akt signaling	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-389513	CTLA4 inhibitory signaling	 14	0.336213754518406	1	3	11	568	3325	1.46622466850138
R-HSA-389661	Glyoxylate metabolism and glycine degradation	 14	0.336213754518406	1	3	11	568	3325	1.46622466850138
R-HSA-389948	PD-1 signaling	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-389977	Post-chaperonin tubulin folding pathway	 10	1	1	0	10	571	3326	0
R-HSA-390466	Chaperonin-mediated protein folding	 38	0.670865257260716	1	5	33	566	3303	0.900313392939441
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	 14	0.336213754518406	1	3	11	568	3325	1.46622466850138
R-HSA-390522	Striated Muscle Contraction	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	 14	0.136060472170459	1	4	10	567	3326	1.9549662246685
R-HSA-390918	Peroxisomal lipid metabolism	  7	1	1	0	7	571	3329	0
R-HSA-391160	Signal regulatory protein family interactions	  7	1	1	0	7	571	3329	0
R-HSA-391251	Protein folding	 41	0.736362730237576	1	5	36	566	3300	0.834436803212165
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	 16	0.920597828991936	1	1	15	570	3321	0.427648861646235
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	 10	1	1	0	10	571	3326	0
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	 17	0.932250010859221	1	1	16	570	3320	0.40249304625528
R-HSA-392517	Rap1 signalling	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-392518	Signal amplification	 14	1	1	0	14	571	3322	0
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-3928662	EPHB-mediated forward signaling	 21	0.61126238275627	1	3	18	568	3318	0.977483112334251
R-HSA-3928663	EPHA-mediated growth cone collapse	 11	1	1	0	11	571	3325	0
R-HSA-3928664	Ephrin signaling	  6	1	1	0	6	571	3330	0
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	 28	0.931249168083512	1	2	26	569	3310	0.488741556167125
R-HSA-397795	G-protein beta:gamma signalling	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-399719	Trafficking of AMPA receptors	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-399954	Sema3A PAK dependent Axon repulsion	  5	1	1	0	5	571	3331	0
R-HSA-399956	CRMPs in Sema3A signaling	  6	1	1	0	6	571	3330	0
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	 14	1	1	0	14	571	3322	0
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	 59	0.236015479014313	1	11	48	560	3288	1.27569829914809
R-HSA-400253	Circadian Clock	 41	0.566545219319966	1	6	35	565	3301	1.0013241638546
R-HSA-400508	Incretin synthesis, secretion, and inactivation	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-400685	Sema4D in semaphorin signaling	 11	1	1	0	11	571	3325	0
R-HSA-4085001	Sialic acid metabolism	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-4086398	Ca2+ pathway	 35	0.405515738048461	1	6	29	565	3307	1.1729797348011
R-HSA-4086400	PCP/CE pathway	 35	0.405515738048461	1	6	29	565	3307	1.1729797348011
R-HSA-416476	G alpha (q) signalling events	 63	0.987763704041684	1	4	59	567	3277	0.434436938815223
R-HSA-416482	G alpha (12/13) signalling events	 40	0.856893935560437	1	4	36	567	3300	0.684238178633976
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	  9	1	1	0	9	571	3327	0
R-HSA-416700	Other semaphorin interactions	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-417957	P2Y receptors	  6	1	1	0	6	571	3330	0
R-HSA-418038	Nucleotide-like (purinergic) receptors	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-418217	G beta:gamma signalling through PLC beta	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-418346	Platelet homeostasis	 50	0.759689619065431	1	6	44	565	3292	0.821085814360771
R-HSA-418359	Reduction of cytosolic Ca++ levels	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-418360	Platelet calcium homeostasis	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-418457	cGMP effects	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-418555	G alpha (s) signalling events	 50	0.983640361668713	1	3	47	568	3289	0.410542907180385
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	 10	1	1	0	10	571	3326	0
R-HSA-418594	G alpha (i) signalling events	 75	0.937001666970622	1	7	68	564	3268	0.638622300058377
R-HSA-418597	G alpha (z) signalling events	 26	0.983791772068707	1	1	25	570	3311	0.263168530243837
R-HSA-418885	DCC mediated attractive signaling	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-418886	Netrin mediated repulsion signals	  6	1	1	0	6	571	3330	0
R-HSA-418889	Ligand-independent caspase activation via DCC	  5	1	1	0	5	571	3331	0
R-HSA-418990	Adherens junctions interactions	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-419037	NCAM1 interactions	 22	0.643921485683122	1	3	19	568	3317	0.933052061773603
R-HSA-419408	Lysosphingolipid and LPA receptors	  7	1	1	0	7	571	3329	0
R-HSA-419812	Calcitonin-like ligand receptors	  5	1	1	0	5	571	3331	0
R-HSA-420029	Tight junction interactions	  5	1	1	0	5	571	3331	0
R-HSA-420092	Glucagon-type ligand receptors	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	  7	1	1	0	7	571	3329	0
R-HSA-421270	Cell-cell junction organization	 18	0.942194803609705	1	1	17	570	3319	0.38013232146332
R-HSA-421837	Clathrin derived vesicle budding	 40	0.986212290228923	1	2	38	569	3298	0.342119089316988
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-422356	Regulation of insulin secretion	 44	0.309344602850425	1	8	36	563	3300	1.24406941569814
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	 34	0.89300998360734	1	3	31	568	3305	0.60373956938292
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	 47	0.541797727141162	1	7	40	564	3296	1.01907813839103
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	 13	1	1	0	13	571	3323	0
R-HSA-425407	SLC-mediated transmembrane transport	 98	0.868022849492191	1	11	87	560	3249	0.768022445405483
R-HSA-425410	Metal ion SLC transporters	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-425561	Sodium/Calcium exchangers	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-426496	Post-transcriptional silencing by small RNAs	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-427359	SIRT1 negatively regulates rRNA expression	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	 15	0.906945724310935	1	1	14	570	3322	0.456158785755984
R-HSA-427413	NoRC negatively regulates rRNA expression	 31	0.0718924288377822	1	8	23	563	3313	1.76577594486187
R-HSA-428157	Sphingolipid metabolism	 39	0.514780130193637	1	6	33	565	3303	1.05267412097535
R-HSA-428540	Activation of RAC1	  7	1	1	0	7	571	3329	0
R-HSA-428542	Regulation of commissural axon pathfinding by SLIT and ROBO	  5	1	1	0	5	571	3331	0
R-HSA-428930	Thromboxane signalling through TP receptor	  9	1	1	0	9	571	3327	0
R-HSA-429914	Deadenylation-dependent mRNA decay	 22	0.404421397552873	1	4	18	567	3318	1.24406941569814
R-HSA-429947	Deadenylation of mRNA	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-430116	GP1b-IX-V activation signalling	  6	1	1	0	6	571	3330	0
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-432142	Platelet sensitization by LDL	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-432720	Lysosome Vesicle Biogenesis	 18	0.942194803609705	1	1	17	570	3319	0.38013232146332
R-HSA-432722	Golgi Associated Vesicle Biogenesis	 33	0.964371709729202	1	2	31	569	3305	0.414689805232712
R-HSA-435354	Zinc transporters	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-437239	Recycling pathway of L1	 29	0.630478492576954	1	4	25	567	3311	0.943776798115828
R-HSA-438064	Post NMDA receptor activation events	 25	0.729986805349405	1	3	22	568	3314	0.821085814360771
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-4420097	VEGFA-VEGFR2 Pathway	 53	0.807747793623398	1	6	47	565	3289	0.774609258830916
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 10	0.169677539283834	1	3	7	568	3329	2.05271453590193
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	  5	1	1	0	5	571	3331	0
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-442742	CREB phosphorylation through the activation of Ras	 20	0.576655301532624	1	3	17	568	3319	1.02635726795096
R-HSA-442755	Activation of NMDA receptor and postsynaptic events	 29	0.818251067074086	1	3	26	568	3310	0.707832598586871
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-444257	RSK activation	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-445095	Interaction between L1 and Ankyrins	 19	0.950682015525071	1	1	18	570	3318	0.360125357175777
R-HSA-445144	Signal transduction by L1	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-445355	Smooth Muscle Contraction	 21	0.964105780351709	1	1	20	570	3316	0.325827704111417
R-HSA-445717	Aquaporin-mediated transport	 23	0.870371372779869	1	2	21	569	3315	0.594989720551283
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	 28	0.988210783913994	1	1	27	570	3309	0.244370778083563
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	 22	0.969379995333483	1	1	21	570	3315	0.311017353924534
R-HSA-446353	Cell-extracellular matrix interactions	  8	1	1	0	8	571	3328	0
R-HSA-446652	Interleukin-1 family signaling	 49	0.741844276176443	1	6	43	565	3293	0.837842667715072
R-HSA-446728	Cell junction organization	 28	0.988210783913994	1	1	27	570	3309	0.244370778083563
R-HSA-447043	Neurofascin interactions	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-447115	Interleukin-12 family signaling	 27	0.921790393076702	1	2	25	569	3311	0.506843095284426
R-HSA-448424	Interleukin-17 signaling	 41	0.0292557103354061	1	11	30	560	3306	1.83576096706676
R-HSA-449836	Other interleukin signaling	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	 25	0.0612837958456678	1	7	18	564	3318	1.91586690017513
R-HSA-450294	MAP kinase activation in TLR cascade	 39	0.0489850120551085	1	10	29	561	3307	1.75445686829225
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	 10	0.0457342025998273	1	4	6	567	3330	2.7369527145359
R-HSA-450341	Activation of the AP-1 family of transcription factors	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	  8	0.0986415063991545	1	3	5	568	3331	2.56589316987741
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	  9	0.132494538278632	1	3	6	568	3330	2.28079392877992
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	 35	0.405515738048461	1	6	29	565	3307	1.1729797348011
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-451306	Ionotropic activity of kainate receptors	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-451326	Activation of kainate receptors upon glutamate binding	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-451927	Interleukin-2 family signaling	 14	1	1	0	14	571	3322	0
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-453274	Mitotic G2-G2/M phases	 86	0.494414224134226	1	13	73	558	3263	1.03431352584206
R-HSA-453276	Regulation of mitotic cell cycle	 28	0.601598527359927	1	4	24	567	3312	0.977483112334251
R-HSA-453279	Mitotic G1-G1/S phases	 50	0.450596657388305	1	8	42	563	3294	1.09478108581436
R-HSA-4551638	SUMOylation of chromatin organization proteins	 30	0.657981025406859	1	4	26	567	3310	0.912317571511967
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	 13	1	1	0	13	571	3323	0
R-HSA-4570464	SUMOylation of RNA binding proteins	 23	0.870371372779869	1	2	21	569	3315	0.594989720551283
R-HSA-4608870	Asymmetric localization of PCP proteins	 22	0.404421397552873	1	4	18	567	3318	1.24406941569814
R-HSA-4615885	SUMOylation of DNA replication proteins	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-4641257	Degradation of AXIN	 19	0.540178666327839	1	3	16	568	3320	1.08037607152733
R-HSA-4641258	Degradation of DVL	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-4641263	Regulation of FZD by ubiquitination	  7	1	1	0	7	571	3329	0
R-HSA-4641265	Repression of WNT target genes	  8	0.0986415063991545	1	3	5	568	3331	2.56589316987741
R-HSA-4791275	Signaling by WNT in cancer	 18	0.263250502546824	1	4	14	567	3322	1.52052928585328
R-HSA-4839726	Chromatin organization	 97	0.106841324381525	1	19	78	552	3258	1.3402603499016
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-500657	Presynaptic function of Kainate receptors	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-5099900	WNT5A-dependent internalization of FZD4	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	 19	0.950682015525071	1	1	18	570	3318	0.360125357175777
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-5173105	O-linked glycosylation	 27	0.359186595652749	1	5	22	566	3314	1.26710773821107
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-5205647	Mitophagy	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-5210891	Uptake and function of anthrax toxins	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-5213460	RIPK1-mediated regulated necrosis	  7	1	1	0	7	571	3329	0
R-HSA-5218859	Regulated Necrosis	  7	1	1	0	7	571	3329	0
R-HSA-5218920	VEGFR2 mediated vascular permeability	 13	0.293323765443846	1	3	10	568	3326	1.57901118146302
R-HSA-5218921	VEGFR2 mediated cell proliferation	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-5223345	Miscellaneous transport and binding events	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	 31	0.684070322305086	1	4	27	567	3309	0.882887972430936
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	 25	0.729986805349405	1	3	22	568	3314	0.821085814360771
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	 32	0.035044852330599	1	9	23	562	3313	1.92441987740806
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-525793	Myogenesis	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-5260271	Diseases of Immune System	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	 16	0.196449115808452	1	4	12	567	3324	1.71059544658494
R-HSA-5334118	DNA methylation	  9	1	1	0	9	571	3327	0
R-HSA-5336415	Uptake and function of diphtheria toxin	  5	1	1	0	5	571	3331	0
R-HSA-5339562	Uptake and actions of bacterial toxins	 20	0.576655301532624	1	3	17	568	3319	1.02635726795096
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	 12	1	1	0	12	571	3324	0
R-HSA-5357786	TNFR1-induced proapoptotic signaling	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-5357801	Programmed Cell Death	 77	0.331162261706725	1	13	64	558	3272	1.15520731457684
R-HSA-5357905	Regulation of TNFR1 signaling	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-5358346	Hedgehog ligand biogenesis	 23	0.439437111853512	1	4	19	567	3317	1.18997944110257
R-HSA-5358351	Signaling by Hedgehog	 70	0.32107513329338	1	12	58	559	3278	1.1729797348011
R-HSA-5358508	Mismatch Repair	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-5362517	Signaling by Retinoic Acid	 21	0.61126238275627	1	3	18	568	3318	0.977483112334251
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	 19	0.298114441378495	1	4	15	567	3321	1.44050142870311
R-HSA-5365859	RA biosynthesis pathway	 10	1	1	0	10	571	3326	0
R-HSA-5368286	Mitochondrial translation initiation	 24	0.977720320035534	1	1	23	570	3313	0.28509924109749
R-HSA-5368287	Mitochondrial translation	 27	0.777694768992292	1	3	24	568	3312	0.760264642926639
R-HSA-5387390	Hh mutants abrogate ligand secretion	 19	0.298114441378495	1	4	15	567	3321	1.44050142870311
R-HSA-5389840	Mitochondrial translation elongation	 25	0.899090205630941	1	2	23	569	3313	0.54739054290718
R-HSA-539107	Activation of E2F1 target genes at G1/S	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-5419276	Mitochondrial translation termination	 24	0.885561933608418	1	2	22	569	3314	0.57019848219498
R-HSA-5423646	Aflatoxin activation and detoxification	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-549132	Organic cation/anion/zwitterion transport	  6	1	1	0	6	571	3330	0
R-HSA-5576886	Phase 4 - resting membrane potential	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-5576891	Cardiac conduction	 77	0.583064147904337	1	11	66	560	3270	0.977483112334251
R-HSA-5576892	Phase 0 - rapid depolarisation	 26	0.539959654440555	1	4	22	567	3314	1.05267412097535
R-HSA-5576893	Phase 2 - plateau phase	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-5578749	Transcriptional regulation by small RNAs	 34	0.968831817611818	1	2	32	569	3304	0.40249304625528
R-HSA-5578775	Ion homeostasis	 37	0.646808444609437	1	5	32	566	3304	0.92464618734321
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	  9	1	1	0	9	571	3327	0
R-HSA-5602358	Diseases associated with the TLR signaling cascade	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-5602498	MyD88 deficiency (TLR2/4)	  5	1	1	0	5	571	3331	0
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	  5	1	1	0	5	571	3331	0
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	 23	0.674594141757564	1	3	20	568	3316	0.892484580826925
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-5607764	CLEC7A (Dectin-1) signaling	 43	0.442813871192955	1	7	36	564	3300	1.11387610475298
R-HSA-5610780	Degradation of GLI1 by the proteasome	 20	0.333477733500725	1	4	16	567	3320	1.36847635726795
R-HSA-5610783	Degradation of GLI2 by the proteasome	 20	0.576655301532624	1	3	17	568	3319	1.02635726795096
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	 21	0.61126238275627	1	3	18	568	3318	0.977483112334251
R-HSA-5610787	Hedgehog 'off' state	 53	0.368407016535983	1	9	44	562	3292	1.16191388824637
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	 31	0.684070322305086	1	4	27	567	3309	0.882887972430936
R-HSA-5619084	ABC transporter disorders	 23	0.238096754624837	1	5	18	566	3318	1.48747430137821
R-HSA-5619102	SLC transporter disorders	 21	0.964105780351709	1	1	20	570	3316	0.325827704111417
R-HSA-5619115	Disorders of transmembrane transporters	 44	0.63878329697613	1	6	38	565	3298	0.933052061773603
R-HSA-5619507	Activation of HOX genes during differentiation	 31	0.684070322305086	1	4	27	567	3309	0.882887972430936
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	 51	0.776613212183442	1	6	45	565	3291	0.804986092510559
R-HSA-5620916	VxPx cargo-targeting to cilium	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-5620920	Cargo trafficking to the periciliary membrane	 29	0.421098744753512	1	5	24	566	3312	1.17972099764479
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-5620924	Intraflagellar transport	 31	0.852343334536178	1	3	28	568	3308	0.662165979323202
R-HSA-5621481	C-type lectin receptors (CLRs)	 55	0.412806539386172	1	9	46	562	3290	1.11966247412832
R-HSA-5621575	CD209 (DC-SIGN) signaling	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-5625740	RHO GTPases activate PKNs	 27	0.921790393076702	1	2	25	569	3311	0.506843095284426
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	 12	1	1	0	12	571	3324	0
R-HSA-5625900	RHO GTPases activate CIT	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-5625970	RHO GTPases activate KTN1	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-5626467	RHO GTPases activate IQGAPs	 14	0.890951145316818	1	1	13	570	3323	0.488741556167125
R-HSA-5627117	RHO GTPases Activate ROCKs	  8	1	1	0	8	571	3328	0
R-HSA-5627123	RHO GTPases activate PAKs	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-5628897	TP53 Regulates Metabolic Genes	 45	0.110743851786564	1	10	35	561	3301	1.52052928585328
R-HSA-5632684	Hedgehog 'on' state	 32	0.511455901089704	1	5	27	566	3309	1.06912215411559
R-HSA-5633007	Regulation of TP53 Activity	 67	0.267191743879207	1	12	55	559	3281	1.22550121546384
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	 22	0.643921485683122	1	3	19	568	3317	0.933052061773603
R-HSA-5635838	Activation of SMO	  7	1	1	0	7	571	3329	0
R-HSA-5637810	Constitutive Signaling by EGFRvIII	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-5637812	Signaling by EGFRvIII in Cancer	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-5654687	Downstream signaling of activated FGFR1	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-5654688	SHC-mediated cascade:FGFR1	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-5654689	PI-3K cascade:FGFR1	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-5654693	FRS-mediated FGFR1 signaling	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-5654695	PI-3K cascade:FGFR2	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-5654696	Downstream signaling of activated FGFR2	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-5654699	SHC-mediated cascade:FGFR2	  8	1	1	0	8	571	3328	0
R-HSA-5654700	FRS-mediated FGFR2 signaling	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-5654704	SHC-mediated cascade:FGFR3	  8	1	1	0	8	571	3328	0
R-HSA-5654706	FRS-mediated FGFR3 signaling	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-5654708	Downstream signaling of activated FGFR3	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-5654710	PI-3K cascade:FGFR3	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-5654712	FRS-mediated FGFR4 signaling	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-5654716	Downstream signaling of activated FGFR4	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-5654719	SHC-mediated cascade:FGFR4	  7	1	1	0	7	571	3329	0
R-HSA-5654720	PI-3K cascade:FGFR4	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-5654726	Negative regulation of FGFR1 signaling	 14	0.0420618470870275	1	5	9	566	3327	2.44370778083563
R-HSA-5654727	Negative regulation of FGFR2 signaling	 13	0.109203722146622	1	4	9	567	3327	2.10534824195069
R-HSA-5654732	Negative regulation of FGFR3 signaling	 13	0.109203722146622	1	4	9	567	3327	2.10534824195069
R-HSA-5654733	Negative regulation of FGFR4 signaling	 12	0.0850238917166143	1	4	8	567	3328	2.28079392877992
R-HSA-5654736	Signaling by FGFR1	 25	0.146970553330286	1	6	19	565	3317	1.64217162872154
R-HSA-5654738	Signaling by FGFR2	 35	0.595511801195865	1	5	30	566	3306	0.977483112334251
R-HSA-5654741	Signaling by FGFR3	 20	0.333477733500725	1	4	16	567	3320	1.36847635726795
R-HSA-5654743	Signaling by FGFR4	 19	0.298114441378495	1	4	15	567	3321	1.44050142870311
R-HSA-5655253	Signaling by FGFR2 in disease	 18	0.942194803609705	1	1	17	570	3319	0.38013232146332
R-HSA-5655291	Signaling by FGFR4 in disease	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-5655302	Signaling by FGFR1 in disease	 24	0.126405731533978	1	6	18	565	3318	1.71059544658494
R-HSA-5655332	Signaling by FGFR3 in disease	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-5655862	Translesion synthesis by POLK	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-5656121	Translesion synthesis by POLI	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-5656169	Termination of translesion DNA synthesis	 14	0.890951145316818	1	1	13	570	3323	0.488741556167125
R-HSA-5658442	Regulation of RAS by GAPs	 28	0.216534288591796	1	6	22	565	3314	1.46622466850138
R-HSA-5660526	Response to metal ions	 10	1	1	0	10	571	3326	0
R-HSA-5661231	Metallothioneins bind metals	  7	1	1	0	7	571	3329	0
R-HSA-5663084	Diseases of carbohydrate metabolism	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-5663220	RHO GTPases Activate Formins	 55	0.56482021217589	1	8	47	563	3289	0.99525553255851
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	  5	1	1	0	5	571	3331	0
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	 30	0.836058849481556	1	3	27	568	3309	0.684238178633976
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	  5	1	1	0	5	571	3331	0
R-HSA-5668914	Diseases of metabolism	 26	0.539959654440555	1	4	22	567	3314	1.05267412097535
R-HSA-5673000	RAF activation	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-5674135	MAP2K and MAPK activation	 22	1	1	0	22	571	3314	0
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-5675221	Negative regulation of MAPK pathway	 23	0.439437111853512	1	4	19	567	3317	1.18997944110257
R-HSA-5675482	Regulation of necroptotic cell death	  6	1	1	0	6	571	3330	0
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	 23	0.674594141757564	1	3	20	568	3316	0.892484580826925
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	  5	1	1	0	5	571	3331	0
R-HSA-5678895	Defective CFTR causes cystic fibrosis	 21	0.369012814190748	1	4	17	567	3319	1.30331081644567
R-HSA-5682910	LGI-ADAM interactions	  9	1	1	0	9	571	3327	0
R-HSA-5683826	Surfactant metabolism	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	 14	0.336213754518406	1	3	11	568	3325	1.46622466850138
R-HSA-5685942	HDR through Homologous Recombination (HRR)	 17	0.229238396858391	1	4	13	567	3323	1.60997218502112
R-HSA-5686938	Regulation of TLR by endogenous ligand	  8	1	1	0	8	571	3328	0
R-HSA-5687128	MAPK6/MAPK4 signaling	 41	0.736362730237576	1	5	36	566	3300	0.834436803212165
R-HSA-5689603	UCH proteinases	 34	0.377642973330823	1	6	28	565	3308	1.20747913876584
R-HSA-5689877	Josephin domain DUBs	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-5689880	Ub-specific processing proteases	 81	0.766248942258925	1	10	71	561	3265	0.84473849214071
R-HSA-5689896	Ovarian tumor domain proteases	 14	0.336213754518406	1	3	11	568	3325	1.46622466850138
R-HSA-5689901	Metalloprotease DUBs	 12	0.541687939030397	1	2	10	569	3326	1.14039696438996
R-HSA-5693532	DNA Double-Strand Break Repair	 51	0.324540826796877	1	9	42	562	3294	1.20747913876584
R-HSA-5693538	Homology Directed Repair	 41	0.566545219319966	1	6	35	565	3301	1.0013241638546
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	 24	0.703275203665827	1	3	21	568	3315	0.855297723292469
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	 39	0.693818952417639	1	5	34	566	3302	0.877228434146123
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	 12	0.0850238917166143	1	4	8	567	3328	2.28079392877992
R-HSA-5693606	DNA Double Strand Break Response	 24	0.703275203665827	1	3	21	568	3315	0.855297723292469
R-HSA-5693607	Processing of DNA double-strand break ends	 31	0.684070322305086	1	4	27	567	3309	0.882887972430936
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	 12	0.0850238917166143	1	4	8	567	3328	2.28079392877992
R-HSA-5694530	Cargo concentration in the ER	 16	0.920597828991936	1	1	15	570	3321	0.427648861646235
R-HSA-5696394	DNA Damage Recognition in GG-NER	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-5696395	Formation of Incision Complex in GG-NER	 26	0.168935234518577	1	6	20	565	3316	1.57901118146302
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-5696398	Nucleotide Excision Repair	 52	0.220246190335039	1	10	42	561	3294	1.31584265121918
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	 43	0.16637608360423	1	9	34	562	3302	1.43212642039669
R-HSA-5696400	Dual Incision in GG-NER	 20	0.156661272889579	1	5	15	566	3321	1.71059544658494
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-611105	Respiratory electron transport	 33	0.00158252977196636	0.250460729904586	12	21	559	3315	2.48813883139627
R-HSA-622312	Inflammasomes	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-674695	RNA Polymerase II Pre-transcription Events	 30	0.268032322608216	1	6	24	565	3312	1.36847635726795
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	 25	0.0612837958456678	1	7	18	564	3318	1.91586690017513
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	 36	0.144634482709848	1	8	28	563	3308	1.52052928585328
R-HSA-6782135	Dual incision in TC-NER	 29	0.119397837517549	1	7	22	564	3314	1.6516093967027
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	 27	0.0876113938705627	1	7	20	564	3316	1.77395083349549
R-HSA-6782315	tRNA modification in the nucleus and cytosol	 17	0.00142194378489737	0.250460729904586	8	9	563	3327	3.21994437004224
R-HSA-6783310	Fanconi Anemia Pathway	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-6783589	Interleukin-6 family signaling	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-6783783	Interleukin-10 signaling	 18	1	1	0	18	571	3318	0
R-HSA-6784531	tRNA processing in the nucleus	 29	0.939619397787913	1	2	27	569	3309	0.471888399057914
R-HSA-6785631	ERBB2 Regulates Cell Motility	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-6785807	Interleukin-4 and 13 signaling	 51	0.885711107118149	1	5	46	566	3290	0.6708217437588
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	  8	1	1	0	8	571	3328	0
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-6790901	rRNA modification in the nucleus and cytosol	 15	1	1	0	15	571	3321	0
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	 35	0.774190467852666	1	4	31	567	3305	0.781986489867401
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	 20	0.156661272889579	1	5	15	566	3321	1.71059544658494
R-HSA-6794361	Neurexins and neuroligins	 36	0.996706112061904	1	1	35	570	3301	0.19006616073166
R-HSA-6794362	Protein-protein interactions at synapses	 56	0.97281963575054	1	4	52	567	3284	0.488741556167125
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	 25	0.00168681025559133	0.250460729904586	10	15	561	3321	2.7369527145359
R-HSA-6799198	Complex I biogenesis	 16	0.071706320731058	1	5	11	566	3325	2.13824430823117
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	 22	0.969379995333483	1	1	21	570	3315	0.311017353924534
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	 20	1	1	0	20	571	3316	0
R-HSA-6802949	Signaling by RAS mutants	 30	0.451712029182571	1	5	25	566	3311	1.14039696438996
R-HSA-6802952	Signaling by BRAF and RAF fusions	 32	0.867199935487935	1	3	29	568	3307	0.641473292469352
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	 22	0.969379995333483	1	1	21	570	3315	0.311017353924534
R-HSA-6802957	Oncogenic MAPK signaling	 41	0.242373264711943	1	8	33	563	3303	1.33509888513946
R-HSA-6803157	Antimicrobial peptides	 15	0.906945724310935	1	1	14	570	3322	0.456158785755984
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	  6	1	1	0	6	571	3330	0
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	  6	1	1	0	6	571	3330	0
R-HSA-6803529	FGFR2 alternative splicing	 15	0.906945724310935	1	1	14	570	3322	0.456158785755984
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	  7	0.0689222844016876	1	3	4	568	3332	2.93244933700275
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	 35	0.595511801195865	1	5	30	566	3306	0.977483112334251
R-HSA-6804757	Regulation of TP53 Degradation	 17	0.229238396858391	1	4	13	567	3323	1.60997218502112
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-6804760	Regulation of TP53 Activity through Methylation	  9	0.132494538278632	1	3	6	568	3330	2.28079392877992
R-HSA-6805567	Keratinization	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-6806003	Regulation of TP53 Expression and Degradation	 17	0.229238396858391	1	4	13	567	3323	1.60997218502112
R-HSA-6806667	Metabolism of fat-soluble vitamins	 19	0.950682015525071	1	1	18	570	3318	0.360125357175777
R-HSA-6806834	Signaling by MET	 40	0.986212290228923	1	2	38	569	3298	0.342119089316988
R-HSA-6807004	Negative regulation of MET activity	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-6807070	PTEN Regulation	 54	0.821995979544008	1	6	48	565	3288	0.760264642926639
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	 31	0.481878271343823	1	5	26	566	3310	1.10360996553867
R-HSA-6807878	COPI-mediated anterograde transport	 44	0.791822045913944	1	5	39	566	3297	0.777543384811336
R-HSA-6809371	Formation of the cornified envelope	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	 36	0.97619440032137	1	2	34	569	3302	0.38013232146332
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	 28	0.0147426174304745	1	9	19	562	3317	2.19933700275206
R-HSA-6811438	Intra-Golgi traffic	 24	0.473826708399727	1	4	20	567	3316	1.14039696438996
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	 32	0.176497733265409	1	7	25	564	3311	1.49677101576182
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	 97	0.243827863344201	1	17	80	554	3256	1.19918031306985
R-HSA-6811555	PI5P Regulates TP53 Acetylation	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	 46	0.35595934624432	1	8	38	563	3298	1.18997944110257
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-68689	CDC6 association with the ORC:origin complex	  5	1	1	0	5	571	3331	0
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	 22	0.853347265734451	1	2	20	569	3316	0.622034707849069
R-HSA-68867	Assembly of the pre-replicative complex	 23	0.870371372779869	1	2	21	569	3315	0.594989720551283
R-HSA-68874	M/G1 Transition	 28	0.931249168083512	1	2	26	569	3310	0.488741556167125
R-HSA-68875	Mitotic Prophase	 47	0.703367574195594	1	6	41	565	3295	0.873495547192309
R-HSA-68877	Mitotic Prometaphase	 91	0.348413942666435	1	15	76	556	3260	1.12786512961644
R-HSA-68882	Mitotic Anaphase	 79	0.491154978979009	1	12	67	559	3269	1.03934913210224
R-HSA-68884	Mitotic Telophase/Cytokinesis	 10	0.169677539283834	1	3	7	568	3329	2.05271453590193
R-HSA-68949	Orc1 removal from chromatin	 24	0.885561933608418	1	2	22	569	3314	0.57019848219498
R-HSA-68962	Activation of the pre-replicative complex	 11	1	1	0	11	571	3325	0
R-HSA-69002	DNA Replication Pre-Initiation	 28	0.931249168083512	1	2	26	569	3310	0.488741556167125
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-69052	Switching of origins to a post-replicative state	 24	0.885561933608418	1	2	22	569	3314	0.57019848219498
R-HSA-69091	Polymerase switching	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-69109	Leading Strand Synthesis	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-69186	Lagging Strand Synthesis	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-69190	DNA strand elongation	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-69202	Cyclin E associated events during G1/S transition 	 28	0.102837157114125	1	7	21	564	3315	1.71059544658494
R-HSA-69205	G1/S-Specific Transcription	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-69206	G1/S Transition	 44	0.309344602850425	1	8	36	563	3300	1.24406941569814
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	 17	0.462173416449949	1	3	14	568	3322	1.20747913876584
R-HSA-69231	Cyclin D associated events in G1	 17	0.0898839523961524	1	5	12	566	3324	2.0124652312764
R-HSA-69236	G1 Phase	 17	0.0898839523961524	1	5	12	566	3324	2.0124652312764
R-HSA-69239	Synthesis of DNA	 33	0.731958220294921	1	4	29	567	3307	0.829379610465425
R-HSA-69242	S Phase	 51	0.202452144891336	1	10	41	561	3295	1.3416434875176
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	  9	0.387220966957504	1	2	7	569	3329	1.52052928585328
R-HSA-69275	G2/M Transition	 86	0.494414224134226	1	13	73	558	3263	1.03431352584206
R-HSA-69298	Association of licensing factors with the pre-replicative complex	  6	1	1	0	6	571	3330	0
R-HSA-69300	Removal of licensing factors from origins	 25	0.899090205630941	1	2	23	569	3313	0.54739054290718
R-HSA-69304	Regulation of DNA replication	 25	0.899090205630941	1	2	23	569	3313	0.54739054290718
R-HSA-69306	DNA Replication	 35	0.774190467852666	1	4	31	567	3305	0.781986489867401
R-HSA-69473	G2/M DNA damage checkpoint	 33	0.540321486882625	1	5	28	566	3308	1.03672451308178
R-HSA-69481	G2/M Checkpoints	 56	0.730582581029052	1	7	49	564	3287	0.855297723292469
R-HSA-69541	Stabilization of p53	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-69563	p53-Dependent G1 DNA Damage Response	 23	0.870371372779869	1	2	21	569	3315	0.594989720551283
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	 23	0.870371372779869	1	2	21	569	3315	0.594989720551283
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-69610	p53-Independent DNA Damage Response	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	 17	0.734162919115383	1	2	15	569	3321	0.804986092510559
R-HSA-69615	G1/S DNA Damage Checkpoints	 23	0.870371372779869	1	2	21	569	3315	0.594989720551283
R-HSA-69618	Mitotic Spindle Checkpoint	 45	0.332517835831291	1	8	37	563	3299	1.21642342868262
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	 26	0.168935234518577	1	6	20	565	3316	1.57901118146302
R-HSA-70171	Glycolysis	 40	0.540978675534585	1	6	34	565	3302	1.02635726795096
R-HSA-70221	Glycogen breakdown (glycogenolysis)	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-70263	Gluconeogenesis	 16	0.196449115808452	1	4	12	567	3324	1.71059544658494
R-HSA-70268	Pyruvate metabolism	 16	0.196449115808452	1	4	12	567	3324	1.71059544658494
R-HSA-70326	Glucose metabolism	 48	0.261062744931084	1	9	39	562	3297	1.2829465849387
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-70895	Branched-chain amino acid catabolism	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-71064	Lysine catabolism	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-71403	Citric acid cycle (TCA cycle)	 12	0.0850238917166143	1	4	8	567	3328	2.28079392877992
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	 30	0.0607674407426464	1	8	22	563	3314	1.82463514302393
R-HSA-72086	mRNA Capping	 14	0.0420618470870275	1	5	9	566	3327	2.44370778083563
R-HSA-72163	mRNA Splicing - Major Pathway	 78	0.0958019013305416	1	16	62	555	3274	1.4035654946338
R-HSA-72165	mRNA Splicing - Minor Pathway	 18	0.501957999230575	1	3	15	568	3321	1.14039696438996
R-HSA-72172	mRNA Splicing	 81	0.0738643479186539	1	17	64	554	3272	1.43605543663921
R-HSA-72187	mRNA 3'-end processing	 28	0.216534288591796	1	6	22	565	3314	1.46622466850138
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	 40	0.715653277686648	1	5	35	566	3301	0.855297723292469
R-HSA-72306	tRNA processing	 49	0.168847754987541	1	10	39	561	3297	1.39640444619179
R-HSA-72312	rRNA processing	 39	0.693818952417639	1	5	34	566	3302	0.877228434146123
R-HSA-72613	Eukaryotic Translation Initiation	 19	0.950682015525071	1	1	18	570	3318	0.360125357175777
R-HSA-72649	Translation initiation complex formation	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-72689	Formation of a pool of free 40S subunits	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	 12	0.850261609243988	1	1	11	570	3325	0.57019848219498
R-HSA-72702	Ribosomal scanning and start codon recognition	 14	0.890951145316818	1	1	13	570	3323	0.488741556167125
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	 18	0.942194803609705	1	1	17	570	3319	0.38013232146332
R-HSA-72737	Cap-dependent Translation Initiation	 19	0.950682015525071	1	1	18	570	3318	0.360125357175777
R-HSA-72764	Eukaryotic Translation Termination	  8	1	1	0	8	571	3328	0
R-HSA-72766	Translation	 84	0.701673030180056	1	11	73	560	3263	0.896026186306396
R-HSA-73728	RNA Polymerase I Promoter Opening	 10	1	1	0	10	571	3326	0
R-HSA-73762	RNA Polymerase I Transcription Initiation	 21	0.024892640856657	1	7	14	564	3322	2.28079392877992
R-HSA-73772	RNA Polymerase I Promoter Escape	 13	0.00651972741231602	0.662295642967769	6	7	565	3329	3.15802236292604
R-HSA-73776	RNA Polymerase II Promoter Escape	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-73777	RNA Polymerase I Chain Elongation	 22	0.0899037756917286	1	6	16	565	3320	1.86610412354721
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-73780	RNA Polymerase III Chain Elongation	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-73854	RNA Polymerase I Promoter Clearance	 31	0.156302125375514	1	7	24	564	3312	1.54505395175414
R-HSA-73856	RNA Polymerase II Transcription Termination	 30	0.137241871318607	1	7	23	564	3313	1.59655575014594
R-HSA-73863	RNA Polymerase I Transcription Termination	 14	0.00184917684096905	0.250460729904586	7	7	564	3329	3.42119089316988
R-HSA-73864	RNA Polymerase I Transcription	 31	0.156302125375514	1	7	24	564	3312	1.54505395175414
R-HSA-73884	Base Excision Repair	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-73886	Chromosome Maintenance	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-73887	Death Receptor Signalling	 26	0.75477295546795	1	3	23	568	3313	0.78950559073151
R-HSA-73893	DNA Damage Bypass	 21	0.834308558457058	1	2	19	569	3317	0.651655408222834
R-HSA-73933	Resolution of Abasic Sites (AP sites)	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-73980	RNA Polymerase III Transcription Termination	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-74158	RNA Polymerase III Transcription	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-74182	Ketone body metabolism	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-74217	Purine salvage	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-74259	Purine catabolism	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-74749	Signal attenuation	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-74751	Insulin receptor signalling cascade	 24	0.267489129122432	1	5	19	566	3317	1.42549620548745
R-HSA-74752	Signaling by Insulin receptor	 38	0.181147845648135	1	8	30	563	3306	1.44050142870311
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	 13	0.109203722146622	1	4	9	567	3327	2.10534824195069
R-HSA-75105	Fatty acyl-CoA biosynthesis	 19	0.000109247212534957	0.044390784026704	10	9	561	3327	3.60125357175777
R-HSA-75153	Apoptotic execution  phase	 29	0.421098744753512	1	5	24	566	3312	1.17972099764479
R-HSA-75205	Dissolution of Fibrin Clot	  5	1	1	0	5	571	3331	0
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	 17	0.462173416449949	1	3	14	568	3322	1.20747913876584
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	 14	0.00184917684096905	0.250460729904586	7	7	564	3329	3.42119089316988
R-HSA-75892	Platelet Adhesion to exposed collagen	  7	1	1	0	7	571	3329	0
R-HSA-75893	TNF signaling	 22	0.643921485683122	1	3	19	568	3317	0.933052061773603
R-HSA-75953	RNA Polymerase II Transcription Initiation	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-75955	RNA Polymerase II Transcription Elongation	 23	0.107352953032041	1	6	17	565	3319	1.78496916165385
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	 62	0.907888174104315	1	6	56	565	3280	0.662165979323202
R-HSA-76009	Platelet Aggregation (Plug Formation)	 16	0.920597828991936	1	1	15	570	3321	0.427648861646235
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	 18	0.110196026948875	1	5	13	566	3323	1.9006616073166
R-HSA-76046	RNA Polymerase III Transcription Initiation	 13	0.109203722146622	1	4	9	567	3327	2.10534824195069
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	 12	0.0213502171580283	1	5	7	566	3329	2.8509924109749
R-HSA-77111	Synthesis of Ketone Bodies	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-77387	Insulin receptor recycling	 15	0.165263417039104	1	4	11	567	3325	1.82463514302393
R-HSA-774815	Nucleosome assembly	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-77595	Processing of Intronless Pre-mRNAs	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-844456	The NLRP3 inflammasome	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-877300	Interferon gamma signaling	 42	0.59140727601406	1	6	36	565	3300	0.977483112334251
R-HSA-877312	Regulation of IFNG signaling	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-879518	Transport of organic anions	  5	1	1	0	5	571	3331	0
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	 73	0.987522104592934	1	5	68	566	3268	0.4686562867356
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-8848021	Signaling by PTK6	 25	0.297618773070469	1	5	20	566	3316	1.36847635726795
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-8849932	Synaptic adhesion-like molecules	 11	1	1	0	11	571	3325	0
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	  6	1	1	0	6	571	3330	0
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 10	1	1	0	10	571	3326	0
R-HSA-8851805	MET activates RAS signaling	  6	1	1	0	6	571	3330	0
R-HSA-8852135	Protein ubiquitination	 32	0.511455901089704	1	5	27	566	3309	1.06912215411559
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	 26	0.911116643144524	1	2	24	569	3312	0.526337060487673
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-8853659	RET signaling	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	 20	0.333477733500725	1	4	16	567	3320	1.36847635726795
R-HSA-8854214	TBC/RABGAPs	 16	0.421067236522028	1	3	13	568	3323	1.2829465849387
R-HSA-8854518	AURKA Activation by TPX2	 38	0.931554083964144	1	3	35	568	3301	0.540188035763665
R-HSA-8856688	Golgi-to-ER retrograde transport	 57	0.201956858388027	1	11	46	560	3290	1.32045964297785
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	 57	0.85975749355529	1	6	51	565	3285	0.720250714351553
R-HSA-8856828	Clathrin-mediated endocytosis	 80	0.636467284595411	1	11	69	560	3267	0.940827495621716
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-8863678	Neurodegenerative Diseases	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-8863795	Downregulation of ERBB2 signaling	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-8866427	VLDLR internalisation and degradation	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	 12	0.250834524682948	1	3	9	568	3327	1.71059544658494
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	 23	0.674594141757564	1	3	20	568	3316	0.892484580826925
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	  5	1	1	0	5	571	3331	0
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	  5	0.157639765681268	1	2	3	569	3333	2.7369527145359
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	  6	1	1	0	6	571	3330	0
R-HSA-8868773	rRNA processing in the nucleus and cytosol	 37	0.811005737308644	1	4	33	567	3303	0.739716949874568
R-HSA-8873719	RAB geranylgeranylation	 36	0.433288922899037	1	6	30	565	3306	1.14039696438996
R-HSA-8874081	MET activates PTK2 signaling	 15	1	1	0	15	571	3321	0
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	  8	0.717819127219476	1	1	7	570	3329	0.855297723292469
R-HSA-8875555	MET activates RAP1 and RAC1	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-8875878	MET promotes cell motility	 20	0.957924960261487	1	1	19	570	3317	0.342119089316988
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	 44	0.047304743376819	1	11	33	560	3303	1.71059544658494
R-HSA-8876384	Listeria monocytogenes entry into host cells	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-8876725	Protein methylation	  9	0.0309354426401994	1	4	5	567	3331	3.04105857170656
R-HSA-8878159	Transcriptional regulation by RUNX3	 52	0.0326485687099986	1	13	39	558	3297	1.71059544658494
R-HSA-8878166	Transcriptional regulation by RUNX2	 50	0.185303278529955	1	10	40	561	3296	1.36847635726795
R-HSA-8878171	Transcriptional regulation by RUNX1	 86	0.180831396311545	1	16	70	555	3266	1.27300126257484
R-HSA-888590	GABA synthesis, release, reuptake and degradation	 17	0.229238396858391	1	4	13	567	3323	1.60997218502112
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-8934903	Receptor Mediated Mitophagy	  6	0.0440755673312621	1	3	3	568	3333	3.42119089316988
R-HSA-8935964	RUNX1 regulates expression of components of tight junctions	  5	1	1	0	5	571	3331	0
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	 30	0.451712029182571	1	5	25	566	3311	1.14039696438996
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	 35	0.774190467852666	1	4	31	567	3305	0.781986489867401
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	 19	0.0477148530071662	1	6	13	565	3323	2.16075214305466
R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	  5	0.546348100735411	1	1	4	570	3332	1.36847635726795
R-HSA-8939902	Regulation of RUNX2 expression and activity	 26	0.32825771082092	1	5	21	566	3315	1.31584265121918
R-HSA-8940973	RUNX2 regulates osteoblast differentiation	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-8941326	RUNX2 regulates bone development	 16	0.70216415409592	1	2	14	569	3322	0.855297723292469
R-HSA-8941856	RUNX3 regulates NOTCH signaling	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-8941858	Regulation of RUNX3 expression and activity	 19	0.298114441378495	1	4	15	567	3321	1.44050142870311
R-HSA-8943723	Regulation of PTEN mRNA translation	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-8943724	Regulation of PTEN gene transcription	 20	1	1	0	20	571	3316	0
R-HSA-8948216	Collagen chain trimerization	 18	0.763188534100984	1	2	16	569	3320	0.760264642926639
R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-8948751	Regulation of PTEN stability and activity	 26	0.32825771082092	1	5	21	566	3315	1.31584265121918
R-HSA-8949215	Mitochondrial calcium ion transport	 10	0.169677539283834	1	3	7	568	3329	2.05271453590193
R-HSA-8949613	Cristae formation	 13	0.00105648802366324	0.250460729904586	7	6	564	3330	3.68435942341371
R-HSA-8949664	Processing of SMDT1	  6	0.0440755673312621	1	3	3	568	3333	3.42119089316988
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	 15	1	1	0	15	571	3321	0
R-HSA-8951430	RUNX3 regulates WNT signaling	  8	0.0986415063991545	1	3	5	568	3331	2.56589316987741
R-HSA-8951664	Neddylation	 99	0.372044609117312	1	16	83	555	3253	1.10583948062057
R-HSA-8951671	RUNX3 regulates YAP1-mediated transcription	 15	0.378951338888233	1	3	12	568	3324	1.36847635726795
R-HSA-8951936	RUNX3 regulates p14-ARF	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-8953750	Transcriptional Regulation by E2F6	  9	0.0309354426401994	1	4	5	567	3331	3.04105857170656
R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	 13	0.586845061500678	1	2	11	569	3325	1.05267412097535
R-HSA-8956319	Nucleobase catabolism	 15	0.667027039399183	1	2	13	569	3323	0.912317571511967
R-HSA-8956321	Nucleotide salvage	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-8957275	Post-translational protein phosphorylation	 43	0.774431278989192	1	5	38	566	3298	0.795625789109274
R-HSA-8957322	Metabolism of steroids	 67	0.0559490404800729	1	15	52	556	3284	1.5318765193298
R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-8963898	Plasma lipoprotein assembly	  8	1	1	0	8	571	3328	0
R-HSA-8963899	Plasma lipoprotein remodeling	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-8964038	LDL clearance	 10	0.794425794294034	1	1	9	570	3327	0.684238178633976
R-HSA-8964043	Plasma lipoprotein clearance	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-8978868	Fatty acid metabolism	 68	0.111540829223748	1	14	54	557	3282	1.40872566189348
R-HSA-8979227	Triglyceride metabolism	 15	0.906945724310935	1	1	14	570	3322	0.456158785755984
R-HSA-8982491	Glycogen metabolism	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-8983432	Interleukin-15 signaling	  6	1	1	0	6	571	3330	0
R-HSA-8984722	Interleukin-35 Signalling	 10	0.441606823875921	1	2	8	569	3328	1.36847635726795
R-HSA-9006921	Integrin signaling	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	 25	0.297618773070469	1	5	20	566	3316	1.36847635726795
R-HSA-9006931	Signaling by Nuclear Receptors	 21	0.61126238275627	1	3	18	568	3318	0.977483112334251
R-HSA-9006936	Signaling by TGF-beta family members	 57	0.201956858388027	1	11	46	560	3290	1.32045964297785
R-HSA-9007101	Rab regulation of trafficking	 54	0.0857311876007709	1	12	42	559	3294	1.52052928585328
R-HSA-901032	ER Quality Control Compartment (ERQC)	  8	0.330615093917755	1	2	6	569	3330	1.71059544658494
R-HSA-901042	Calnexin/calreticulin cycle	 11	0.209381866441365	1	3	8	568	3328	1.86610412354721
R-HSA-9010553	Regulation of expression of SLITs and ROBOs	 37	0.923338723593954	1	3	34	568	3302	0.554787712405926
R-HSA-9010642	ROBO receptors bind AKAP5	  6	1	1	0	6	571	3330	0
R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-909733	Interferon alpha/beta signaling	 38	0.670865257260716	1	5	33	566	3303	0.900313392939441
R-HSA-912446	Meiotic recombination	 14	0.890951145316818	1	1	13	570	3323	0.488741556167125
R-HSA-912526	Interleukin receptor SHC signaling	  8	1	1	0	8	571	3328	0
R-HSA-912631	Regulation of signaling by CBL	 11	0.824547136726189	1	1	10	570	3326	0.622034707849069
R-HSA-912694	Regulation of IFNA signaling	  8	0.0986415063991545	1	3	5	568	3331	2.56589316987741
R-HSA-913531	Interferon Signaling	 98	0.581932395996758	1	14	84	557	3252	0.977483112334251
R-HSA-913709	O-linked glycosylation of mucins	 14	0.628616945997723	1	2	12	569	3324	0.977483112334251
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	 12	1	1	0	12	571	3324	0
R-HSA-917937	Iron uptake and transport	 35	0.595511801195865	1	5	30	566	3306	0.977483112334251
R-HSA-917977	Transferrin endocytosis and recycling	 19	0.298114441378495	1	4	15	567	3321	1.44050142870311
R-HSA-918233	TRAF3-dependent IRF activation pathway	  6	0.214421864856271	1	2	4	569	3332	2.28079392877992
R-HSA-927802	Nonsense-Mediated Decay (NMD)	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-933541	TRAF6 mediated IRF7 activation	 11	0.063799333530419	1	4	7	567	3329	2.48813883139627
R-HSA-933542	TRAF6 mediated NF-kB activation	 12	1	1	0	12	571	3324	0
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	  5	1	1	0	5	571	3331	0
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	 18	1	1	0	18	571	3318	0
R-HSA-936837	Ion transport by P-type ATPases	 32	0.959302158049083	1	2	30	569	3306	0.427648861646235
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	  7	1	1	0	7	571	3329	0
R-HSA-937039	IRAK1 recruits IKK complex	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-937041	IKK complex recruitment mediated by RIP1	  9	0.759143897252223	1	1	8	570	3328	0.760264642926639
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	 54	0.257557061740381	1	10	44	561	3292	1.26710773821107
R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-948021	Transport to the Golgi and subsequent modification	 77	0.893835780456592	1	8	69	563	3267	0.710896808970364
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	  7	0.272621697038105	1	2	5	569	3331	1.9549662246685
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	 52	0.220246190335039	1	10	42	561	3294	1.31584265121918
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-975155	MyD88 dependent cascade initiated on endosome	 54	0.155367680569759	1	11	43	560	3293	1.39381851203217
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	  7	0.669418623056761	1	1	6	570	3330	0.977483112334251
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	  6	0.612733347911239	1	1	5	570	3331	1.14039696438996
R-HSA-975634	Retinoid metabolism and transport	 19	0.950682015525071	1	1	18	570	3318	0.360125357175777
R-HSA-975871	MyD88 cascade initiated on plasma membrane	 49	0.091825723047435	1	11	38	560	3298	1.53604489081097
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	 10	1	1	0	10	571	3326	0
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	 19	0.789424989133118	1	2	17	569	3319	0.720250714351553
R-HSA-977225	Amyloid fiber formation	 24	0.885561933608418	1	2	22	569	3314	0.57019848219498
R-HSA-977441	GABA A receptor activation	  9	1	1	0	9	571	3327	0
R-HSA-977443	GABA receptor activation	 30	1	1	0	30	571	3306	0
R-HSA-977444	GABA B receptor activation	 21	1	1	0	21	571	3315	0
R-HSA-977606	Regulation of Complement cascade	 16	1	1	0	16	571	3320	0
R-HSA-982772	Growth hormone receptor signaling	 11	0.493212369972488	1	2	9	569	3327	1.24406941569814
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	 13	0.872212988222597	1	1	12	570	3324	0.526337060487673
R-HSA-983189	Kinesins	 25	1	1	0	25	571	3311	0
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	 71	0.602870837139017	1	10	61	561	3275	0.963715744554895
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	 18	0.0370725585590749	1	6	12	565	3324	2.28079392877992
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	 52	0.346369936754006	1	9	43	562	3293	1.18425838609727
R-HSA-983712	Ion channel transport	 84	0.93911858529355	1	8	76	563	3260	0.651655408222834
R-HSA-991365	Activation of GABAB receptors	 21	1	1	0	21	571	3315	0
R-HSA-997269	Inhibition of adenylate cyclase pathway	  8	1	1	0	8	571	3328	0
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	 13	1	1	0	13	571	3323	0
